Endothelin 1 and cyclic guanosine monophosphate in nonimmunological progression of mesangial proliferative glomerulonephritis.
Roccatello
D
D
Istituto di Nefrourologia, dell'Università di Torino, Italia.
Ferro
M
M
Mengozzi
G
G
Bonetti
G
G
Polloni
R
R
Mosso
R
R
Paradisi
L
L
Sena
L M
LM
Piccoli
G
G
D006152:Cyclic GMP / Q000096:biosynthesis* / Q000652:urine; D018450:Disease Progression; D016232:Endothelins / Q000378:metabolism* / Q000652:urine; D005922:Glomerulonephritis, IGA / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology* / Q000652:urine; D015432:Glomerulonephritis, Membranoproliferative / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology* / Q000652:urine; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy / Q000209:etiology / Q000652:urine; D007548:Isosorbide Dinitrate / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D009569:Nitric Oxide / Q000378:metabolism; D010865:Pilot Projects; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use
D016232:Endothelins; D014665:Vasodilator Agents; D009569:Nitric Oxide; D006152:Cyclic GMP; D007548:Isosorbide Dinitrate; C030397:isosorbide-5-mononitrate